Femasys (FEMY) Non-Current Debt (2020)
Femasys' (FEMY) quarterly Non-Current Debt came in at $182490.0 in Q4 2020.
Powered by 
Analysis
Femasys (FEMY) Non-Current Debt (2020) Analysis & Trends
Femasys (FEMY) has reported Non-Current Debt for 1 consecutive years, with $182490.0 the latest figure, recorded in Q4 2020.
- For the quarter ending Q4 2020, Non-Current Debt changed N/A year-over-year to $182490.0; the trailing twelve-month figure through Dec 2020 stood at $182490.0 (changed N/A YoY), and the FY2020 full-year result was $182490.0, changed N/A from the prior year.
- Non-Current Debt steadied at $182490.0 in Q4 2020 per FEMY's latest filing.
- Across five years, Non-Current Debt topped out at $182490.0 in Q4 2020 and bottomed at $182490.0 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 25.62 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 14.19 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 10.92 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 598.70 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -1.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Femasys | 9.01 Mn | 7.57 Mn | 189,391.00 | - |